why choose us

First received: July 25, 2022

Clinical Trial: A Study to Evaluate the Efficacy and Safety of HR19042 Capsules in the Treatment of Autoimmune Hepatitis.

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Autoimmune Hepatitis

Study Type: INTERVENTIONAL


Official Title: A Randomized, Open-label, Multicenter, Phase II Clinical Trial to Evaluate the Efficacy and Safety of HR19042 Capsules in the Treatment of Autoimmune Hepatitis.

Brief Summary: This study will evaluate the efficacy and safety of HR19042 capsules for the treatment of autoimmune hepatitis.It will also explore the optimal frequency and dosage of HR19042 capsules administration for the treatment.

Read more